Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities.

Rheingans R, Anderson JD 4th, Anderson B, Chakraborty P, Atherly D, Pindolia D.

Vaccine. 2014 Aug 11;32 Suppl 1:A140-50. doi: 10.1016/j.vaccine.2014.05.073.

2.

Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.

Megiddo I, Colson AR, Nandi A, Chatterjee S, Prinja S, Khera A, Laxminarayan R.

Vaccine. 2014 Aug 11;32 Suppl 1:A151-61. doi: 10.1016/j.vaccine.2014.04.080.

3.

Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.

Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R.

Vaccine. 2013 Oct 1;31(42):4902-10. doi: 10.1016/j.vaccine.2013.07.014. Epub 2013 Jul 16.

PMID:
23871824
4.

Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.

Rheingans R, Atherly D, Anderson J.

Vaccine. 2012 Apr 27;30 Suppl 1:A15-23. doi: 10.1016/j.vaccine.2012.01.018.

PMID:
22520124
5.

Cost-effectiveness analysis of rotavirus vaccination in Argentina.

Urueña A, Pippo T, Betelu MS, Virgilio F, Hernández L, Giglio N, Gentile Á, Diosque M, Vizzotti C.

Vaccine. 2015 May 7;33 Suppl 1:A126-34. doi: 10.1016/j.vaccine.2014.12.074.

PMID:
25919152
6.

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.

Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S16-27. doi: 10.1086/605026. Review.

PMID:
19817595
7.

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.

Vaccine. 2012 Apr 27;30 Suppl 1:A7-14. doi: 10.1016/j.vaccine.2011.12.096.

PMID:
22520139
8.

Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries.

Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T.

Rev Panam Salud Publica. 2007 Apr;21(4):205-16.

PMID:
17612464
9.

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.

Shim E, Galvani AP.

Vaccine. 2009 Jun 19;27(30):4025-30. doi: 10.1016/j.vaccine.2009.04.030. Epub 2009 May 3.

PMID:
19389452
10.

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.

Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.

J Infect Dis. 2005 Nov 15;192(10):1720-6. Epub 2005 Oct 14.

PMID:
16235169
11.

Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana.

Abbott C, Tiede B, Armah G, Mahmoud A.

Vaccine. 2012 Mar 28;30(15):2582-7. doi: 10.1016/j.vaccine.2012.01.076. Epub 2012 Feb 7.

PMID:
22321664
12.

Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.

Patel HD, Roberts ET, Constenla DO.

Vaccine. 2013 Dec 9;31(51):6072-8. doi: 10.1016/j.vaccine.2013.10.022. Epub 2013 Oct 29.

13.

Economic impact of a rotavirus vaccination program in Mexico.

Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y.

Rev Panam Salud Publica. 2009 Jun;25(6):481-90.

14.

Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.

Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S195-202. doi: 10.1086/605040.

PMID:
19817600
15.

[Economic impact of rotavirus vaccination in Panama].

Constenla D, Ortega-Barría E, Rheingans RD, Antil L, Sáez-Llorens X.

An Pediatr (Barc). 2008 Feb;68(2):128-35. Spanish.

16.

[Potential cost effectiveness of a rotavirus vaccine in Chile].

Constenla D, O'Ryan M, Navarrete MS, Antil L, Rheingans RD.

Rev Med Chil. 2006 Jun;134(6):679-88. Epub 2006 Aug 14. Spanish.

17.

Cost-effectiveness of rotavirus vaccination programs in Taiwan.

Chang WC, Yen C, Chi CL, Wu FT, Huang YC, Lin JS, Huang FC, Tate JE, Wu HS, Hsiung CA.

Vaccine. 2013 Nov 4;31(46):5458-65. doi: 10.1016/j.vaccine.2013.08.103. Epub 2013 Sep 20.

PMID:
24060569
18.

Cost-effectiveness of rotavirus vaccination in Albania.

Ahmeti A, Preza I, Simaku A, Nelaj E, Clark AD, Felix Garcia AG, Lara C, Hoestlandt C, Blau J, Bino S.

Vaccine. 2015 May 7;33 Suppl 1:A201-8. doi: 10.1016/j.vaccine.2014.12.075.

PMID:
25919162
19.

Cost-effectiveness and potential impact of rotavirus vaccination in the United States.

Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI.

Pediatrics. 2007 Apr;119(4):684-97.

PMID:
17403839
20.

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S133-45.

PMID:
16088797

Supplemental Content

Support Center